American Society of Health-System Pharmacists
ASHP Therapeutic Position Statement on the safe use of niacin in the management of dyslipidemias. American Society of Health-System Pharmacists
Abstract
ASHP supports the use of niacin as an effective therapy for the management of dyslipidemias in adults. Successful and safe therapy requires ongoing supervision and instruction by qualified health care providers to monitor the efficacy of therapy and minimize niacin's potential for adverse effects. Because many niacin products are available without a prescription, pharmacists are in a unique position to help ensure that patients make the best use of this medication.
Source and rights
Published by American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- American Society of Health-System Pharmacists
- Published
- 1997
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
- PubMed
- 9428952